Guidance

Cervical screening: pathway for acceptance of new HPV tests

This guidance outlines the process for accepting new human papillomavirus (HPV) tests for use in UK cervical screening programmes.

From:
Public Health England
Published
5 July 2019
Last updated
20 February 2024 — See all updates

Documents

Cervical screening: pathway for acceptance of new human papillomavirus tests

Ref: PHE publications gateway number: GW-501

HTML

Appendix A: application process for commercial providers

Ref: PHE publications gateway number: GW-501

HTML

Appendix B: new technology supplier checklist

Ref: PHE publications gateway number: GW-501

HTML

Details

This document sets out:

  • the pathway for accepting new human papillomavirus tests for cervical screening
  • the application process for commercial providers (Appendix A)
  • a checklist for commercial providers submitting information to support their application (Appendix B)
Published 5 July 2019
Last updated 20 February 2024 + show all updates

  1. Added the 7. Verification of a new pre-analytic system in the 'Cervical screening: pathway for acceptance of new human papillomavirus tests' document

  2. Added acceptance criteria and elaborated on stress test and validation report in section 3 in pathways and minor corrections in appendix A and B.

  3. First published.

Related content